{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-177791","form_type":"8-K","ticker":"BIIB","cik":"0000875045","company_name":"BIOGEN INC.","filed_at":"2022-06-21T23:59:59+00:00","discovered_at":"2026-05-14T18:04:04.052196+00:00","generated_at":"2026-06-25T00:39:58.509463+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Biogen EVP Chirfi Guindo to depart June 30; say-on-pay passes with 48% against","bullets":["Chirfi Guindo, EVP Global Product Strategy, leaves June 30, 2022 for a role outside Biogen.","All 11 director nominees elected; Richard Mulligan received 77.4M for, 38.3M against.","PwC ratified as 2022 auditor with 123.8M votes for and 2.3M against.","Advisory say-on-pay approved: 60.1M for, 55.3M against (47.9% against), indicating shareholder concern.","No other material changes reported."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-177791","json":"https://secwatch.observer/filing/0001193125-22-177791.json","markdown":"https://secwatch.observer/filing/0001193125-22-177791.md","text":"https://secwatch.observer/filing/0001193125-22-177791.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/875045/000119312522177791/0001193125-22-177791-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/875045/000119312522177791/d367101d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T00:39:58.509463+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5c245304d4","claim":"Chirfi Guindo departed as Executive Vice President for Global Product Strategy and Commercialization at BIOGEN INC..","evidence_excerpt":"On June 21, 2022, Chirfi Guindo, Executive Vice President for Global Product Strategy and Commercialization announced that he has accepted a new role outside of Biogen, Inc. (the “Company”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/875045/000119312522177791/0001193125-22-177791-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"departing"},{"label":"Role","value":"Executive Vice President for Global Product Strategy and Commercialization"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}